Tag: NIH

  • Compression Software for Genomic Analysis Being Designed

    6 July 2015. Engineers at University of Illinois in Urbana and Stanford University in California are tackling the problem of massive data files generated by genomic analyses, an emerging issue as precision medicine harnessing genomics takes hold. A team led by engineering faculty Olgica Milenkovic at Illinois and Tsachy Weissman at Stanford is funded by…

  • Report Evaluates Industry-Academic Biotech Partner Roles

    16 June 2015. A report released today by Biotechnology Industry Organization, or Bio, indicates academic research labs are playing an increasingly key role in research and development of new therapies, but it also highlights areas where partnerships between academia and industry are still evolving. Bio released the report, Advancing Translational Research for Biomedical Innovation: Measuring…

  • Grant Funds Exosome Cancer Research, Optioned to Spin-Off

    9 June 2015. A new $1.7 million grant from National Cancer Institute is funding research at University of New Mexico on harnessing exosomes as potential cancer therapies, with a spin-off company already optioning the technology for commercial development. The alliance between the university and spin-off company, Exovita Biosciences, includes an agreement between the university and…

  • Trial to Test Cancer Drugs Matched to Gene Mutations

    2 June 2015. A new clinical trial will test 20 cancer drugs and drug combinations targeted to specific genetic mutations, regardless of cancer type. The study, known as NCI-Match is a joint project of National Cancer Institute, an agency of National Institutes of Health, and the Ecog-Acrin Cancer Research Group, and announced yesterday at the…

  • Genome Interpretation Database, Quality Effort Underway

    28 May 2015. A program to improve diagnostics and research based on genomic variations is underway that collects genetic data and implements standards for their interpretation. A description of the Clinical Genome Resource or ClinGen program appears in yesterday’s issue of the New England Journal of Medicine. ClinGen is a collaborative effort of  public, academic,…

  • Orphan Status Granted Eye Cancer Treatment

    21 May 2015. Food and Drug Administration designated an experimental treatment for uveal melanoma, a rare and aggressive form of cancer in the eye, as an orphan drug that qualifies for incentives to expedite its development. Aura Biosciences also revealed results of preclinical tests showing the ability of its lead biologic therapy code-named AU-011 to…

  • Lab-On-Chip Device Captures Circulating Tumor Cells

    19 May 2015. Engineers and medical researchers designed a microchip that detects clusters of circulating tumor cells that break away from tumors and can spread cancer throughout the body. The team from a joint Harvard-MIT health sciences technology program and Massachusetts General Hospital in Boston published its findings yesterday in the journal Nature Methods (paid…

  • Clinical Trial Testing West Nile Vaccine

    7 May 2015. A vaccine for West Nile virus, a seasonal infection spread by mosquitoes, is being tested for safety in an early stage clinical trial. The vaccine, code-named HydroVax-001, is being developed in the lab of microbiologist Mark Slifka at Oregon Health and Science University in Beaverton and commercialized by Najit Technologies Inc., a…

  • Cancer Therapy Spin-Off Gets $2M Small Business Grant

    4 May 2015. A three year-old company started by a University at Buffalo microbiologist received a $2 million grant to develop an antibody into a clinical treatment for breast and other types of cancer. For-Robin in Williamsville, New York, received the two-year award from National Cancer Institute, part of National Institutes of Health, under the…

  • Intermediate Trial Shows Ebola Vaccines Safe

    27 March 2015. An intermediate-stage clinical trial in Liberia testing two new vaccines to prevent Ebola infections, shows the vaccines appear to be safe, allowing for larger-scale assessments. Initial results of the trial were reported yesterday by National Institute of Allergy and Infectious Diseases (NIAID), part of National Institutes of Health. The 2014-15 Ebola virus…